DCPH

Deciphera Pharmaceuticals, Inc.

16.05 USD
-0.01 (-0.06%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Deciphera Pharmaceuticals, Inc. stock is up 11.85% since 30 days ago. The next earnings date is May 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 6 February’s closed higher than January. 100% of analysts rate it a buy.

About Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST)